Informazioni personali
Nome e cognome: Fabio Castiglione
Nazionalità: Italiana
GMC: 7541824
Formazione
Nel 2009 il Dott. Castiglione ha conseguito l’abilitazione in Medicina e Chirurgia. Successivamente ha completato la sua formazione specialistica in Urologia presso l’Università Vita Salute San Raffaele di Milano. Da allora è diventato membro sia del Comitato Europeo di Medicina Sessuale che dell’European Board of Urology. In Belgio, il dottor Castiglione ha conseguito il dottorato di ricerca studiando le cellule staminali per la cura della disfunzione erettile. Per approfondire la sua esperienza clinica, ha effettuato un anno di volontariato in India presso l’Istituto di chirurgia uretrale di Pune, dove ha appreso le tecniche chirurgiche più avanzate per trattamento della stenosi uretrale.
Università Vita-Salute San Raffaele
- Urologist Residency in Urology
- 2010 - 2015
Grafico KU Leuven
- KU Leuven
- Doctor of Philosophy - PhD
Regenaritive medicine, STEM CELLS, Urology
- 2015 - 2019
Grafico Università Vita-Salute San Raffaele
- Università Vita-Salute San Raffaele
- Doctor of Medicine - MD
- Medical school
- 2003 - 2009
Licenze e certificazioni:
- Full Professor in Urology
- Ministero dell'Istruzione dell'Università e della Ricerca
- Emissione: feb 2022
Fellow of European Board of Urology (FEBU)
- The European Board of Urology
- Emissione: gen 2018
Fellow of the European Committee of Sexual Medicine (FECSM)
- The Multidisciplinary Committee of Sexual Medicine (MJCSM)
- Emissione: gen 2017
FELASA b-c
- the Federation of European Laboratory Animal Science Associations,
- Emissione: nov 2014
Esperienza lavorativa
Il dottor Castiglione si è trasferito nel Regno Unito nel 2016, completando la sua formazione specialistica in andrologia e diventando infine consultant presso l’UCLH. il dottor Castiglione ha pubblicato più di 80 articoli sottoposti a revisione paritaria ed è professore associato presso l’University College di Londra ed è stato recentemente premiato come il migliore esperto di medicina sessuale europeo nel 2022. Inoltre, ha presentato in numerose conferenze e riunioni a livello nazionale e internazionale sui suoi argomenti specializzati.
Attualmente, il dottor Castiglione è un appassionato ricercatore, e sta conducendo diverse ricerche sulla urologia ricostruttiva, disfunzione erettile post-prostatectomia e strategie di riabilitazione del pene e terapia con cellule staminali, comprese le cellule staminali derivate dal tessuto adiposo (ADSC) e sul plasma ricco di piastrine per la cura dell’ impotenza. Il dottor Castiglione è stato nominato Prostate Cancer UK Champion dalla piu grande charity per il cancro alla prostata nel Regno Unito. Ha l’obiettivo di sviluppare nuovi percorsi clinici e fornire miglioramenti significativi per il trattamento delle disfunzioni sessuali per i pazienti che hanno subito trattamenti per il cancro alla prostata.
Membro di diverse società scientifiche internazionali, tra cui ESSM, ISSM e EAU, il Dr. Fabio Castiglione è pronto ad offrire la sua esperienza e competenza nella cura delle disfunzioni sessuali, infertilità e patologia prostatica.
Urologist Andrologist Consultant
- King's College Hospital NHS Foundation Trust
- gen 2023 - Presente
- London, England, United Kingdom
Andrologist consultant
- Guy's and St Thomas' NHS Foundation Trust
- feb 2023 - Presente
- London, England, United Kingdom
UCL
- 3 anni 11 mesi:
- Hon associate professor in Urology
- ott 2021 - Presente, 2 anni
- Lecturer
- nov 2019 - nov 2021, 2 anni 1 mese
- London, United Kingdom
Urologist Andrologist consultant
- Whittington Health
- lug 2022 - gen 2023, 7 mesi
- London, England, United Kingdom
University College London Hospitals NHS Foundation Trust
- 3 anni 9 mesi:
- Locum Consultant Urologist Andrologist
- nov 2021 - lug 2022, 9 mesi
- London, England, United Kingdom
- Andrology Senior Clinical Fellow
- ott 2019 - lug 2022, 2 anni 10 mesi
- Urology, Oncology robotic fellow
- nov 2018 - ott 2019, 1 anno
- London, United Kingdom
SM EDITOR OF JOURNAL Of SEXUAL MEDICINE
- Journal of sexual medicine
- mar 2018 - lug 2022, 4 anni 5 mesi
Associate Editor-andrology
- The journal of sexual medicine
- gen 2020 - feb 2022, 2 anni 2 mesi
Associate Member of the Examination Committee
- European Board of Urology (EBU)
- mag 2021 - nov 2021, 7 mesi
- London, England, United Kingdom
EAU Guideline for sexual health Senior Associate
- European Association of Urology
- ott 2020 - ott 2021, 1 anno 1 mese
Urology fellow
- Whittington Health
- mar 2018 - ott 2018, 8 mesi
- London, United Kingdom
University College London Hospitals NHS Foundation Trust
- 1 anno 4 mesi:
- Reconstructive Urology Fellow
- nov 2017 - feb 2018, 4 mesi
- London, Greater London, United Kingdom
- Andrology fellow
- nov 2016 - ott 2017, 1 anno
- London
Reconstructive Urology fellow
- Kulkarni urethroplasty institute
- gen 2016 - nov 2016, 11 mesi
- Pune, Maharashtra, India
Nei media
Attualmente, il Dr. Castiglione ricopre il ruolo di Associate Editor della più importante rivista scientifica nell'ambito della medicina sessuale: The Journal of Sexual Medicine. Con oltre 60 pubblicazioni in riviste internazionali, il Dr. Fabio Castiglione si dedica all'innovazione nel campo dell'Urologia e dell'Andrologia, con particolare attenzione alle nuove tecnologie e trattamenti per la cura delle disfunzioni erettili.
Youtube:
LIVE con Dr. Fabio Castiglione, urologo e andrologo italiano a Londra
Miti da sfatare: Masturbazione 01 | Fabio Castiglione
Differenza tra andrologo e urologo | Dr. Fabio Castiglione | Urologo Londra
Pubblicazioni
Cause Comuni di Dolore Testicolare: Cosa Devi Sapere
The Truth About Aphrodisiacs: Separating Science from Folklore
Impotenza e Caffè: Una Miscela Più Forte di un Espresso Doppio!
European Society of Sexual Medicine consensus statement on the use of animal models for studying Peyronie’s disease
The Rho-kinase inhibitor Y27632 promotes ureteral relaxation in an in vivo rat model for partial ureteral obstruction
Therapeutic outcomes and analysis of Doppler findings in 25 patients with non-ischemic priapism
Outcomes following radical inguinal lymphadenectomy for penile cancer using a fascial-sparing surgical technique
Complications and outcomes following injection of foreign material into the male external genitalia for augmentation: a single-centre experience and systematic review
Active surveillance for very small renal masses: Analysis from an observational prospective trial (NCT03804320)
Therapeutic outcomes and analysis of Doppler findings in 25 patients with Non-ischemic Priapism
Diagnostic Accuracy of Dynamic Sentinel Lymph Node Biopsy for Penile Cancer: A Systematic Review and Meta-analysis
The Current Role and Implications of Stem Cell Therapy in Erectile Dysfunction: A Transformation from Caterpillar to Butterfly Is Required
Treatment of Persistent or Recurrent Varicoceles: A Systematic Review
Correction to: News and future perspectives of non-surgical treatments for erectile dysfunction
Erectile Dysfunction, Surgical and Regenerative Therapy
Lymphovascular and perineural invasion are risk factors for inguinal lymph node metastases in men with T1G2 penile cancer
The Effect of Varicocele Treatment on Fertility in Adults: A Systematic Review and Meta-analysis of Published Prospective Trials
Urethroscopic Findings Following Urethroplasty Predict the Need for Secondary Intervention in the Long Term: A Multi-Institutional Study From Trauma and Urologic Reconstructive Network of Surgeons. Letter.
Management of small testicular masses: outcomes from a single centre multidisciplinary team
Surgical technique and outcomes following coronal-sparing glans resurfacing for benign and malignant penile lesions
234 Male genital lichen sclerosus, micro incontinence and occlusion: Mapping the disease across the prepuce
News and future perspectives of non-surgical treatments for erectile dysfunction
Medications mostly associated with priapism events: assessment of the 2015–2020 Food and Drug Administration (FDA) pharmacovigilance database entries
Are finasteride-related penile curvature/Peyronie’s disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases
Urethral fixation to improve urinary continence recovery after radical cystectomy with ileal neobladder: the EAU YAU Reconstructive Working Party point of view
Contemporary Management of Male Anterior Urethral Strictures by Reconstructive Urology Experts—Results from an International Survey among ESGURS Members
Male genital lichen sclerosus, micro incontinence and occlusion: mapping the disease across the prepuce
Inguinal lymphadenectomy for penile cancer using a fascial sparing technique -outcomes from a single centre
Clinical features, molecular characteristics and surgical management of primary penile mucosal melanoma based on the European Association of Urology Penile Cancer Guidelines
Risk factors for inguinal lymph node metastases in men with T1G2 penile cancer: a multi centre collaborative study
Use of grafting materials during penile prosthesis implantation in patients with Peyronie’s disease—a systematic review
Long-term consequences of bilateral cavernous crush injury in normal and diabetic rats: a functional study
Is finasteride intake associated with penile curvature/peyronie’s disease? Assessment of both the food and drug administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases
Drugs associated the most with male-factor infertility: assessment of the 2010–2020 food and drug administration (FDA) pharmacovigilance database
Medications mostly associated with priapism events: assessment of the 2015–2020 food and drug administration (FDA) pharmacovigilance database entries
Reconstructive surgery of the scrotum: a systematic review
PD53-03 LONG TERM OUTCOMES OF DYNAMIC SENTINEL LYMPH NODE BIOPSY (DSNB) FOR CLINICALLY IMPALPABLE (CN0) PENILE CANCER PATIENTS-AN EUROGEN STUDY
PD29-07 DRUGS ASSOCIATED THE MOST WITH MALE-FACTOR INFERTILITY: ASSESSMENT OF THE 2010-2020 FOOD AND DRUG ADMINISTRATION (FDA) PHARMACOVIGILANCE DATABASE
MP40-11 MANAGEMENT OF INDETERMINATE SMALL TESTIS MASSES (STMS): A 10-YEAR SINGLE CENTRE EXPERIENCE
PD30-08 MEDICATIONS MOSTLY ASSOCIATED WITH PRIAPISM EVENTS: ASSESSMENT OF THE 2015-2020 FOOD AND DRUG ADMINISTRATION (FDA) PHARMACOVIGILANCE DATABASE ENTRIES
MP40-17 INGUINAL LYMPHADENECTOMY USING A FASCIAL SPARING TECHNIQUE IN THE MANAGEMENT OF PENILE CANCER – TECHNIQUE AND OUTCOMES FROM A SINGLE CENTRE
MP45-08 ACTIVE SURVEILLANCE FOR SMALL RENAL MASSES: A PROSPECTIVE NON-RANDOMIZED MULTIINSTITUTIONAL STUDY (NCT03804320)
Increased Level of Tumor Necrosis Factor-Alpha (TNF-α) Leads to Downregulation of Nitrergic Neurons Following Bilateral Cavernous Nerve Injury and Modulates Penile Smooth Tone
Development of a predictive model utilising lesion size as a cutoff to predict testicular cancer in patients with small testicular masses
Medications mostly associated with priapism events: Assessment of the 2015-2020 Food and Drug Administration (FDA) pharmacovigilance database entries
Long-term outcomes of Penile Squamous Cell Carcinoma (SCC) patients with sarcomatoid variant compared to non-sarcomatoid group - An eUROGEN study
Long term consequences of bilateral cavernous crush injury in normal and diabetic rats: A functional study
Management of indeterminate Small Testis Masses (STMs): A 10-year single centre experience
Drugs associated the most with retroperitoneal fibrosis: Assessment of the 2015-2020 Food and Drug Administration (FDA) pharmacovigilance database
Management of inflatable penile prosthesis related urethral erosion
Long term outcomes of Dynamic Sentinel Lymph Node Biopsy (DSNB) for clinically impalpable (cN0) penile cancer patients- an eUROGEN study
Multidisciplinary approach and management of patients who seek medical advice for penile size concerns: a narrative review
Management of penile cancer patients during the COVID-19 pandemic: An eUROGEN accelerated Delphi consensus study
Penile Length Measurement: Methodological Challenges and Recommendations, a Systematic Review
THE EFFECT OF CONDITIONED-MEDIUM HUMAN ADIPOSE-DERIVED MESENCHYMAL STEM CELL IN APOPTOSIS OF BLADDER CANCER CELLS
THE EFFECT OF CONDITIONED MEDIUM ADIPOSE DERIVED MESENCHYMAL STEM CELLS IN UROTHELIAL CARCINOMA CULTURE CELLS VIABILITY
The transient receptor potential A1 ion channel (TRPA1) modifies in vivo autonomous ureter peristalsis in rats
Is medicinal ketamine associated with urinary dysfunction issues? Assessment of both the European Medicines Agency (EMA) and the UK Yellow Card Scheme pharmacovigilance database-related reports
Active surveillance for small renal masses: a prospective translational study update (NCT03804320)
European Society for Sexual Medicine Consensus Statement on the Use of the Cavernous Nerve Injury Rodent Model to Study Postradical Prostatectomy Erectile Dysfunction
Increased in Tumor Necrosis Factor-Alpha (TNFA) leads to downregulation of nitrergic neurons after cavernous nerve injury and impairs penile smooth tone
Non-invasive and surgical interventions of penile enhancement for aesthetic or therapeutic purposes: a systematic review
Intratunical injection of autologous adipose stromal vascular fraction reduces collagen III expression in a rat model of chronic penile fibrosis
Surgical management of acquired rectourethral fistula: a retrospective analysis of 52 consecutive patients
MP84-08 TUMOR NECROSIS FACTOR ALPHA IS INCREASED AFTER CAVERNOUS NERVE INJURY AND IMPAIRS REGENERATION OF NITRERGIC NEURONS AND MODULATES PENILE SMOOTH MUSCLE TONE
Stem cell and future treatments
A novel ‘Batman’ scrotectomy technique for the management of scrotal lymphoedema following treatment for penile cancer
Stem-cell regenerative medicine as applied to the penis
Primary Squamous Cell Carcinoma of the Male Proximal Urethra: Outcomes from a Single Centre
Active surveillance for small renal masses ≤2cm: Results from an Italian multi-institutional prospective protocol
A Systematic Review on Ischemic Priapism and Immediate Implantation: Do We Need More Data?
Excision and Primary Anastomosis for Bulbar Urethral Strictures Improves Functional Outcomes and Quality of Life: A Prospective Analysis from a Single Centre
Supplemental Figures 1 and 2
Intratunical Injection of Human Adipose Tissue–Derived Stem Cells Restores Collagen III/I Ratio in a Rat Model of Chronic Peyronie’s Disease
Excision and primary anastomosis for anterior urethral strictures: surgical technique from University Hospitals Leuven
The mechanisms and potential of stem cell therapy for penile fibrosis
Intratunical Injection of Stromal vascular fraction prevents Fibrosis in a Rat Model of Peyronie's Disease
The Management of Peyronie’s Disease
Squamous cell carcinoma of the posterior urethra: Outcomes following radical surgery and adjuvant chemo-radiotherapy
Excision and primary anastomosis for bulbar strictures has a major positive impact on functional outcomes and quality of life: Surgical technique and a prospective analysis from a single center
Galanin Administration Partially Restores Erectile Function After Cavernous Nerve Injury and Mediates Endogenous Nitrergic Nerve Outgrowth In Vitro
Excision and primary anastomosis for bulbar strictures has a major positive impact on functional outcomes and quality of life: a prospective analysis from a single center
Development of the First Model of Radical Prostatectomy in the Mouse: A Feasibility Study
Surgical Techniques for Managing Post-prostatectomy Erectile Dysfunction
Current Management of Penile Fracture: An Up-to-Date Systematic Review
Predictive factors for local recurrence after glansectomy and neoglans reconstruction for penile squamous cell carcinoma
MP41-09 ADIPOSE-DERIVED STROMAL VASCULAR FACTOR (SVF) INJECTION IN SHORT RECURRENT BULBAR STRICTURE POST DVIU – AN INITIAL EXPERIENCE
A novel composite two-stage urethroplasty for complex penile strictures: A multicenter experience
Squamous cell carcinoma of the posterior urethra: Outcomes following radical surgery and adjuvant chemo-radiotherapy.
M1 Macrophages Are Predominantly Recruited to the Major Pelvic Ganglion of the Rat Following Cavernous Nerve Injury
Impaired contraction and decreased detrusor innervation in a female rat model of pelvic neuropraxia
Kallikrein-Kinin system: is it the fountain of youth?
Stem Cells in Male Sexual Dysfunction: Are We Getting Somewhere?
Tumor Volume and Clinical Failure in High-Risk Prostate Cancer Patients Treated With Radical Prostatectomy: Prostatic Tumor Volume Cutoff for Clinical Failure
Current Literature Review
PS-04-006 Osteopontin is a Novel Player in Endogenous Neuroregeneration After BCNI
Adipose-derived Stem Cells Counteract Urethral Stricture Formation in Rats
48 Development of the first model of radical prostatectomy in mouse: A feasibility study with biochemical validation
885 Osteopontin is an important player in endogenous neuroregeneration after cavernous nerve injury
735 What is the prognostic impact of nodal tumour burden in patients with a single positive node at final pathology?
Advances in stem cell research for the treatment of male sexual dysfunctions
Current Pharmacological Management of Premature Ejaculation: A Systematic Review and Meta-analysis
DFL23448, a novel TRPM8-selective ion channel antagonist, modifies bladder function and reduces bladder overactivity in awake rats
Learning to Fly: There's no sensation to compare with this Suspended animation, a state of bliss-Pink Floyd
Comment on: Novel therapeutic approach for neurogenic erectile dysfunction: effect of neurotrophic tyrosine kinase receptor type 1 monoclonal antibody. G Lin, H Li, X Zhang, J Wang, U Zaid, MT Sanford, V Tu, A Wu, L Wang, F Tian, H Kotanides, V Krishnan, G Wang, H Ning, L Banie, CS Lin, GG Deng, TF Lue. Eur Urol 2015 Apr; 67(4):716-26.
Survey of the Literature for September 2015 Issue of Sexual Medicine Journal
Prevention and management of post prostatectomy erectile dysfunction
Pelvic nerve injury negatively impacts female genital blood flow and induces vaginal fibrosis - Implications for human nerve-sparing radical hysterectomy
THE NEUROTROPHIC PEPTIDE GALANIN STIMULATES NEURITE GROWTH OF PELVIC NEURONS
PERIURETHRAL INJECTION OF HUMAN ADIPOSE TISSUE DERIVED STEM CELLS (HADSCS) PREVENTS FIBROSIS IN A NEW RAT MODEL OF URETHRAL STRICTURE
Landmarks in erectile function recovery after radical prostatectomy
MP19-16 HUMAN ADIPOSE TISSUE DERIVED STEM CELLS (HADSCS) PREVENTS FIBROSIS AND BLADDER DYSFUNCTION IN A RAT MODEL OF URETHRAL STRICTURE
MP19-18 INTRATUNICAL INJECTION OF ADIPOSE STROMAL VASCULAR FRACTION (SVF) PREVENTS FIBROSIS EXPRESSION IN A RAT MODEL OF PEYRONIE'S DISEASE
1064 Revision urethroplasty vs primary urethroplasty: Are they really different?
962 Periurethral injection of human adipose tissue derived stem cells prevents fibrosis and counteracts bladder dysfunction in a rat model of iatrogenic urethral stricture
Spinal neuronal cannabinoid receptors mediate urodynamic effects of systemic fatty acid amide hydrolase (FAAH) inhibition in rats: Spinal Cannabinoid Receptors and FAAH in Rat Bladder Dysfunction
Survey of the Literature for March 2015 Issue of Sexual Medicine Journal
AUTOIMMUNE DISEASES ARE HIGHLY COMORBID IN PATIENTS WITH PEYRONIE'S DISEASE - RESULTS OF A CROSS-SECTIONAL REAL LIFE STUDY AMONG CAUCASIAN-EUROPEAN EM
Silodosin and tadalafil have synergistic inhibitory effects on nerve-mediated contractions of human and rat isolated prostates
The Fatty Acid Amide Hydrolase Inhibitor Oleoyl Ethyl Amide Counteracts Bladder Overactivity in Female Rats
Tadalafil for Erectile Dysfunction Prevention After Radiotherapy for Prostate Cancer
Prevalence and predictors of concomitant low sexual desire/interest and new-onset erectile dysfunction - a picture from the everyday clinical practice
Increased Expression of the Neuroregenerative Peptide Galanin in the Major Pelvic Ganglion Following Cavernous Nerve Injury
BIOCHEMICAL RECURRENCE IN MISCLASSIFIED ACTIVE SURVEILLANCE CANDIDATES TREATED WITH RADICAL PROSTATECTOMY
724 Association between tumour volume and unfavourable prostate cancer characteristics: Implications for patient stratification
158 Age blunts clinically-significant differences between men with primary or secondary infertility: Results of a real-life cross-sectional study
487 Intratunical injection of human adipose tissue–derived stem cells partially reverts fibrosis and restores collagen III/I ratio in a rat model of chronic Peyronie's disease
MP43-10 CAVERNOUS NERVE INJURY INDUCED TEMPORAL INCREASE IN NEUROINFLAMMATION AND CYTOKINE INDUCTION IN THE MAJOR PELVIC GANGLION OF THE RAT
MP69-10 GLYCATED HEMOGLOBIN (HBA1C) LEVELS ARE INDEPENDENTLY ASSOCIATED WITH UNFAVOURABLE PROSTATE CANCER AND DISEASE RECURRENCE AFTER RADICAL PROSTATECTOMY
714 Tadalafil OaD improves symptoms associated with Peyronie's disease throughout the acute inflammatory phase: Results of a proof of concept psychometric study
MP68-03 PREVALENCE OF AND IMPACT OF HEALTH-SIGNIFICANT COMORBIDITIES IN CAUCASIAN-EUROPEAN MEN PRESENTING FOR PRIMARY COUPLE’S INFERTILITY – RESULTS OF A CROSS-SECTIONAL SURVEY
651 Renal function impairment after nephron sparing surgery or radical nephrectomy in patients with clinical T1a-T1b renal mass and normal preoperative glomerular filtration rates: Results from a large multi-institutional study
MP59-02 RENAL FUNCTION IMPAIRMENT AFTER NEPHRON SPARING SURGERY OR RADICAL NEPHRECTOMY IN PATIENTS WITH CLINICAL T1A-T1B RENAL MASS AND NORMAL PREOPERATIVE GLOMERULAR FILTRATION RATES: RESULTS FROM A LARGE MULTI-INSTITUTIONAL STUDY
267 Long term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: Results of a single institution series with a minimum follow-up of 5 years
488 Intratunical injection of autologous adipose stromal vascular fraction (SVF) prevents fibrosis in a rat model of Peyronie's disease
498 Inhibition of peripheral fatty acid amide hydrolase (FAAH) increases latency to apomorphine-induced ejaculation in rats
MP48-15 EFFECTS OF SILODOSIN ON SEXUAL FUNCTION – REALISTIC PICTURE FROM THE EVERYDAY CLINICAL PRACTICE
MP30-01 DECREASING RATES OF LYMPH NODE DISSECTION AND LYMPH NODE YIELD DURING RADICAL NEPHRECTOMY FOR RENAL CELL CARCINOMA OVER THE LAST 30 YEARS IN A LARGE MULTICENTRE EUROPEAN EXPERIENCE
686 Reductive cystoplasty and simultaneous prostatic adenomectomy improve symptoms score in patients with chronic obstructive urine retention and detrusor impaired contractility
PD15-12 HYPOGONADISM IS AN INDEPENDENT PREDICTOR OF NODAL METASTASES IN PROSTATE CANCER PATIENTS UNDERGOING EXTENDED PELVIC LYMPH NODE DISSECTION
253 Prevalence and characteristics of metabolic syndrome in Caucasian-European men presenting for primary couple's infertility: Results of a cross-sectional survey
374 DFL23448, a novel TRPM8-selective ion channel antagonist, modifies bladder function and reduces bladder overactivity in awake rats
PELVIC NERVE INJURY LEADS TO INCREASED RHO-KINASE MEDIATED ADRENERGIC VASOCONSTRICTION OF THE DISTAL VAGINA
Valproic Acid Prevents Penile Fibrosis and Erectile Dysfunction in Cavernous Nerve-Injured Rats
VARDENAFIL 10 MG ODT PROMOTES A SATISFACTORY ERECTION IN LESS THAN 30 MINUTES IN ONE PATIENT OUT OF THREE PICTURE FROM THE EVERYDAY CLINICAL PRACTICE
CLINICALLY SIGNIFICANT IMPROVEMENT OF THE IIEF-ERECTILE FUNCTION DOMAIN IS A PROXY OF PATIENT WEANING FROM TADALAFIL OAD CONTINUOUS TREATMENT IN MEN WITH PSYCHOGENIC ERECTILE DYSFUNCTION (ED)
Penile Rehabilitation with Phosphodiesterase Type 5 Inhibitors After Nerve-sparing Radical Prostatectomy: Are We Targeting the Right Patients?
Naftopidil for the treatment of benign prostate hyperplasia: A systematic review
Percentage of High-Grade Tumor Volume does not Meaningfully Improve Prediction of Early Biochemical Recurrence after Radical Prostatectomy Compared to Gleason Score.
The key role of time in predicting progression-free survival in patients with renal cell carcinoma treated with partial or radical nephrectomy: Conditional survival analysis
Secondary Provoked Vestibulodynia in Sexually Active Women with Uncomplicated Recurrent Urinary Tract Infections
When to perform lymph node dissection in patients with renal cell carcinoma: A novel approach to the preoperative assessment of risk of lymph node invasion at surgery and of lymph node progression during follow-up
Erratum: Intratunical injection of human adipose tissue-derived stem cells prevents fibrosis and is associated with improved erectile function in a rat model of peyronie's disease (European Urology (2013) 63 (551-60))
One Patient Out of Four with Newly Diagnosed Erectile Dysfunction Is a Young Man-Worrisome Picture from the Everyday Clinical Practice
Sperm banking is of key importance in patients with prostate cancer
1026 PELVIC NERVE INJURY LEADS TO AUGMENTED ADRENERGIC CONSTRICTION AND FIBROSIS OF THE DISTAL VAGINA
694 Prediction of long-term cancer recurrence after radical prostatectomy in patients with lymph node invasion: Results of conditional survival analysis
114 INHIBITION OF PERIPHERAL FATTY ACID AMIDE HYDROLASE AMELIORATES BLADDER OVERACTIVITY
120 CHOLINERGIC MEDIATED DETRUSOR DYSFUNCTION IN A FEMALE RAT MODEL OF PELVIC NEUROPRAXIA
372 THE NUMBER OF POSITIVE NODES IS THE STRONGEST PREDICTOR OF CANCER SPECIFIC SURVIVAL IN PATIENTS TREATED WITH RADICAL PROSTATECTOMY FOR PATHOLOGICAL T3 PROSTATE CANCER
1975 LONG-TERM ERECTILE FUNCTION OUTCOMES AFTER HOLMIUM LASER ENUCLEATION OF THE PROSTATE (HOLEP)
1831 THE NUMBER OF LYMPH NODES REMOVED IN RENAL CELL CARCINOMA DOES AFFECT CANCER SPECIFIC SURVIVAL IN SPECIFIC SUBGROUPS OF PATIENTS: RESULTS FROM A SYSTEMATIC ANALYSIS
743 CONCORDANCE BETWEEN CLINICAL AND PATHOLOGICAL LYMPH NODE INVASION IN RENAL CELL CARCINOMA
1611 SPINAL ENDOCANNABINOIDS COUNTERACT BLADDER OVERACTIVITY IN RATS
1021 INHIBITION OF THE FATTY ACID AMIDE HYDROLASE INCREASES LATENCY TO APOMORPHINE-INDUCED EJACULATION IN RATS
345 CHANGING AND UNCHANGING FACE OF HIGH RISK PROSTATE CANCER. RESULTS FROM A 15-YEAR, SINGLE INSTITUTION SERIES
714 Spatial distribution of positive cores decreases misclassification rates of patients with low risk prostate cancer candidate for active surveillance
113 TADALAFIL IMPROVES HYPOXIA, STRUCTURAL DETRUSOR CHANGES AND BLADDER COMPLIANCE AFTER CAVERNOUS NERVE INJURY
140 Diabetes mellitus increases the risk of poorly differentiated tumor in prostate cancer patients
69 The peripheral active fatty acid amide hydrolase (FAAH) inhibitor urb937 counteracts detrusor overactivity in two different animal models
326 Galanin, a trophic neuropeptide, is upregulated in the rat major pelvic ganglia following cavernous nerve crush injury
443 Inhibition of spinal cord fatty acid amide hydrolase reduces bladder overactivity in rats
328 Inhibition of the fatty acid amide hydrolase (FAAH) reduces in vivo spontaneous seminal vesicle contractions and increases latency to apomorphine-induced ejaculation
324 Intratunical injection of human adipose tissue-derived stem cells prevents fibrosis and is associated with improved erectile function in a rat model of Peyronie's disease
Inhibition of Phosphodiesterase 4 Enhances Clitoral and Vaginal Blood Flow Responses to Dorsal Clitoral Nerve Stimulation or PGE1 in Anesthetized Female Rats
Reply from Authors re: Ching-Shwun Lin, Tom F. Lue. Adipose-derived Stem Cells for the Treatment of Peyronie's Disease? Eur Urol 2013;63:561–2
Spinal Cord FAAH in Normal Micturition Control and Bladder Overactivity in Awake Rats
The Number Of Cores Taken Is A Major Predictor Of Insignificant Prostate Cancer In Patients Diagnosed With A Single Microfocus At Initial Biopsy: Implications For The Selection Of Candidates Suitable For Active Surveillance.
Corrigendum to “Intratunical Injection of Human Adipose Tissue–derived Stem Cells Prevents Fibrosis and Is Associated with Improved Erectile Function in a Rat Model of Peyronie's Disease” [Eur Urol 2013;63:551–60]
Postoperative phosphodiesterase type 5 inhibitor administration increases the rate of urinary continence recovery after bilateral nerve-sparing radical prostatectomy
Is Erectile Dysfunction a Reliable Proxy of General Male Health Status? The Case for the International Index of Erectile Function-Erectile Function Domain
REDUCED GENITAL BLOOD FLOW IN A RAT MODEL TO SIMULATE AUTONOMIC DYSFUNCTION AFTER NERVE SPARING RADICAL HYSTERECTOMY
PELVIC NERVE INJURY LEADS TO AUGMENTED VAGINAL VASOREACTIVITY IN VITRO AND INCREASED FIBROSIS OF THE DISTAL VAGINA
95 Staging lymphadenectomy in renal cell carcinoma must be extended: A sensitivity curve analyses
Presence of positive surgical margin in patients with organ-confined prostate cancer equals to extracapsular extension negative surgical margin: A plea for TNM staging system reclassification
The Extent of Lymphadenectomy does Affect Cancer Specific Survival in Pathologically Confirmed T4 Renal Cell Carcinoma
Perioperative Betamethasone Treatment Reduces Signs of Bladder Dysfunction in a Rat Model for Neurapraxia in Female Urogenital Surgery
119 PERIOPERATIVE BETAMETHASONE COUNTERACTS BLADDER DYSFUNCTION IN VIVO IN A RAT MODEL FOR NERVE-SPARING HYSTERECTOMY
663 ADJUVANT RADIOTHERAPY NEGATIVELY IMPACTS ON THE LONG-TERM RECOVERY OF NORMAL SEXUAL FUNCTION IN TESTICULAR GERM-CELL CANCER SURVIVORS
771 SHOULD AN EXTENDED NODAL TEMPLATE FOR HIGH RISK PROSTATE CANCER ALWAYS INCLUDE REMOVAL OF COMMON ILIAC LYMPH NODES?
2204 HOW TO EXPAND INDICATIONS FOR ACTIVE SURVEILLANCE WITHOUT COMPROMISING CANCER CONTROL. THE IMPORTANCE OF THE EXTENT OF BIOPSY SAMPLING
1147 IS THE WEB CHANGING THE RELATIONSHIP BETWEEN THE CLINICIANS AND THE URO-ANDROLOGICAL PATIENTS? RESULTS OF AN EXPLORATORY ANALYSIS
2066 MISCLASSIFICATION OF MICRO-FOCUS PROSTATE CANCER DECREASES WITH THE EXTENT OF BIOPSY SAMPLING. IMPORTANCE OF ACCURATE DETECTION
2286 IS SPERM BANKING OF INTEREST TO PATIENTS WITH PROSTATE CANCER?
185 MODELS ASSESSING THE NEED FOR PELVIC LYMPH NODE DISSECTION CANNOT BE RELIABLY USED IN MEN WITH PROSTATE CANCER PREVIOUSLY TREATED WITH SURGERY FOR BENIGN PROSTATIC ENLARGEMENT